STOCK TITAN

Ginkgo Bioworks Announces Date of Third Quarter 2021 Results Presentation

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Ginkgo Bioworks (NYSE: DNA) is set to host a presentation on November 15, 2021, at 8:00 a.m. ET to discuss its third-quarter business performance for the period ending September 30, 2021. Investors can find presentation details and registration on Ginkgo's investor relations website, where a replay will also be available. Questions can be submitted beforehand via Twitter or email. Ginkgo is advancing biotechnology applications in sectors like food, agriculture, and pharmaceuticals, contributing to COVID-19 response efforts such as pooled testing and vaccine optimization.

Positive
  • Upcoming presentation on November 15, 2021, allows investors to gauge Q3 performance.
  • Focus on diverse biotech applications may attract new partnerships and investments.
  • Active involvement in COVID-19 response enhances company reputation and market positioning.
Negative
  • None.

BOSTON, Nov. 8, 2021 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, announced that it plans to host a presentation and Q&A session reviewing business performance for the third quarter ended September 30, 2021, on Monday, November 15, 2021, beginning at 8:00 a.m. ET.

The presentation details and registration link will be available on Ginkgo's investor relations website at www.ginkgobioworks.com/investors and a replay will be made available.

To ask a question ahead of the presentation, please submit them to @Ginkgo on Twitter (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.

About Ginkgo Bioworks

Ginkgo is building a platform to enable customers to program cells as easily as we can program computers. The company's platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo has also actively supported a number of COVID-19 response efforts, including K-12 pooled testing, vaccine manufacturing optimization and therapeutics discovery. For more information, visit www.ginkgobioworks.com.

Ginkgo Bioworks Contacts:

INVESTOR CONTACT:
investors@ginkgobioworks.com  

MEDIA CONTACT:
press@ginkgobioworks.com   

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-third-quarter-2021-results-presentation-301418408.html

SOURCE Ginkgo Bioworks

FAQ

When is Ginkgo Bioworks' Q3 2021 results presentation?

The presentation is scheduled for November 15, 2021, at 8:00 a.m. ET.

Where can I find the registration details for the Ginkgo Bioworks presentation?

Registration details can be found on Ginkgo's investor relations website.

What key business aspects will Ginkgo Bioworks discuss in the Q3 presentation?

Ginkgo will review its business performance for the third quarter ended September 30, 2021.

How can I submit questions for the Ginkgo Bioworks presentation?

Questions can be submitted via Twitter or by email before the presentation.

Ginkgo Bioworks Holdings, Inc.

NYSE:DNA

DNA Rankings

DNA Latest News

DNA Stock Data

386.25M
43.10M
6.44%
61.7%
14.18%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
BOSTON